货号:A208846
同义名:
H 16868 sodium
Omeprazole sodium是一种质子泵(proton pump)抑制剂 (PPI),在胃肠道疾病研究中具有潜力。它竞争性抑制 CYP2C19 的活性。此外,Omeprazole 还能抑制革兰氏阳性菌和革兰氏阴性菌的生长。同时,它也是中性鞘磷脂酶 (N-SMase) 的抑制剂,具有外泌体抑制的作用。
There will be a HazMat fee per item when shipping a dangerous goods. The HazMat fee will be charged to your UPS/DHL/FedEx collect account or added to the invoice unless the package is shipped via Ground service. Ship by air in Excepted Quantity (each bottle), which is up to 1g/1mL for class 6.1 packing group I or II, and up to 25g/25ml for all other HazMat items.
Type | HazMat fee for 500 gram (Estimated) |
Excepted Quantity | USD 0.00 |
Limited Quantity | USD 15-60 |
Inaccessible (Haz class 6.1), Domestic | USD 80+ |
Inaccessible (Haz class 6.1), International | USD 150+ |
Accessible (Haz class 3, 4, 5 or 8), Domestic | USD 100+ |
Accessible (Haz class 3, 4, 5 or 8), International | USD 200+ |
规格 | 价格 | 会员价 | 库存 | 数量 | |||
---|---|---|---|---|---|---|---|
{[ item.pr_size ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]} {[ getRatePriceInt(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]} {[ getRatePriceInt(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} | {[ getRatePrice(item.pr_rmb_sale, 1,1,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate,item.mem_isinteger) ]} | 现货 | 1周 咨询 | - + |
快速发货 顺丰冷链运输,1-2 天到达
品质保证
技术支持
免费溶解
产品名称 | Proton Pump ↓ ↑ | 其他靶点 | 纯度 | ||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Zinc pyrithione | ✔ | 98+% | |||||||||||||||||
PF 03716556 |
++++
H+/K+-ATPase, pIC50: ~6.5 |
99% | |||||||||||||||||
Lansoprazole | ✔ | 98% | |||||||||||||||||
Esomeprazole Magnesium | ✔ | 98%+ | |||||||||||||||||
Rabeprazole | ✔ | 99%+ | |||||||||||||||||
Ilaprazole | ✔ | TOPK | 97% | ||||||||||||||||
Bafilomycin A1 |
++++
H+-ATPase, IC50: 0.44 nM |
99% | |||||||||||||||||
Pantoprazole sodium | ✔ | 98% | |||||||||||||||||
(R)-Lansoprazole | ✔ | 98% | |||||||||||||||||
Tenatoprazole | ✔ | 99%+ | |||||||||||||||||
Omeprazole | ✔ | 98% | |||||||||||||||||
1. 鼠标悬停在“+”上可以显示相关IC50的具体数值。"+"越多,抑制作用越强。2. "✔"表示该化合物对相应的亚型有抑制作用,但抑制强度暂时没有相关数据。 |
描述 | Omeprazole sodium (H 16868 sodium), another form of this proton pump inhibitor, also targets acid-related gastrointestinal disorders and similarly inhibits CYP2C19 activity with a Ki of 2 to 6 μM[1]. This sodium salt form also restricts the growth of both Gram-positive and Gram-negative bacteria[2]. Omeprazole is a significant inhibitor of neutral sphingomyelinase (N-SMase), impacting brain pathways related to exosome production[3]. |
体外研究 | For treating gastrointestinal disorders, Omeprazole (H 16868) has shown to significantly reduce intragastric acidity, with median 24-hour intragastric pH increasing from 1.4 to 5.3 and mean hourly hydrogen ion activity dropping from 38.50 to 1.95 mmol(mEq)/L, surpassing the effectiveness of cimetidine and ranitidine[1]. The pharmacokinetic behavior of omeprazole was evaluated in healthy male subjects who received either single or repeated doses of 30 and 60 mg. The absorption from its enteric-coated formula proved unpredictable, but a significant increase in the area under the plasma concentration-time curve (AUC) was observed after repeated doses, suggesting enhanced bioavailability, likely due to the compound's ability to inhibit its own gastric acid secretion[2]. Omeprazole sodium is a potent inhibitor of neutral sphingomyelinase (N-SMase), effectively penetrating the brain and impacting exosome regulation[3]. |
Concentration | Treated Time | Description | References | |
Human peripheral blood mononuclear cells (PBMC) | 50 μg/mL | 4 and 24 hours | Evaluate the inhibitory effect of omeprazole on LPS-induced inflammatory cytokine production, results showed omeprazole inhibited TNF-α, MCP-1, IL-23, and IL-12 production | Adv Sci (Weinh). 2022 Jan;9(3):e2104051. |
THP-1 cell-derived macrophages | 50 μg/mL | 4 hours | Evaluate the inhibitory effect of omeprazole on TLR4 signaling pathways, results showed omeprazole significantly inhibited NF-κB/AP-1 and IRF activation | Adv Sci (Weinh). 2022 Jan;9(3):e2104051. |
Mouse fundic organ cultures | 80 μmol/ml | 12 hours | To investigate the effect of Ca2+i chelation on Shh gene expression, results showed that EGTA and BAPTA-AM significantly inhibited Shh expression. | Gastroenterology. 2010 Dec;139(6):2061-2071.e2. |
Human saphenous vein segments (SV) | 3 to 100 μM | 24 hours | To study the effect of omeprazole on NO production, results showed that omeprazole significantly inhibited NOx release. | Circulation. 2013 Aug 20;128(8):845-53. |
Human microvascular endothelial cells (HMVECs) | 20 μM | 24 hours | To study the effect of PPIs on ADMA concentration in endothelial cells, results showed that PPIs increased intracellular ADMA by ~30%. | Circulation. 2013 Aug 20;128(8):845-53. |
RAW264.7 macrophages | 50 µM | 72 hours | Test the protective effect of omeprazole on Mycobacterium tuberculosis-infected macrophages, results showed omeprazole failed to protect macrophages at 50 µM | Nat Commun. 2015 Jul 9;6:7659. |
MRC-5 lung fibroblasts | 50 µM | 72 hours | Test the protective effect of omeprazole against Mycobacterium tuberculosis-induced cytotoxicity, results showed omeprazole failed to protect fibroblasts at 50 µM | Nat Commun. 2015 Jul 9;6:7659. |
Administration | Dosage | Frequency | Description | References | ||
Mice | Men1ΔIEC; Sst−/− mice | Oral | 200 ppm chow | 6 months to 1 year | To study the effect of omeprazole on gastrin expression and menin nuclear export in Men1ΔIEC; Sst?/? mice, results showed omeprazole treatment increased gastrin expression and menin nuclear export. | Gastroenterology. 2017 Dec;153(6):1555-1567.e15 |
Mice | Wild-type mice | Intraperitoneal injection | 400 μmol/kg | Once daily for 3 consecutive days | To investigate the effect of omeprazole on gastric acid secretion and Shh gene expression, results showed that omeprazole significantly inhibited gastric acid secretion and Shh gene expression. | Gastroenterology. 2010 Dec;139(6):2061-2071.e2. |
Mice | Wild-type C57BL/6 mice | Intraperitoneal injection | 10 μmol/mouse | Single injection, euthanized after 2 hours | Omeprazole inhibited gastric acid secretion and reduced Shh expression, with additive effect when combined with IL-1β | Gastroenterology. 2010 Feb;138(2):562-72, 572.e1-2 |
Mice | H. pylori infection model | Oral gavage | 1.5 mg/20 g body weight | Once daily for one week | To evaluate the effect of omeprazole on the distribution of H. pylori in the stomach. Results showed that omeprazole-mediated acid suppression promoted H. pylori colonization in the proximal and distal corpus but did not alter its distribution within the gastric glands. | Gastroenterology. 2019 Jan;156(1):160-174.e7 |
Mice | Men1ΔIEC; Sst−/− mouse model | Dietary administration | 200 ppm | 6 months | To investigate the effect of omeprazole on gastric carcinoid development. Results showed that omeprazole treatment accelerated gastric carcinoid formation in Men1ΔIEC; Sst?/? mice, associated with hypergastrinemia. | Gut. 2017 Jun;66(6):1012-1021 |
Mice | Gastric mucosal injury model | Intraperitoneal injection | 60 mg/kg | At least 30 minutes before surgery | Omeprazole reduced maximal damage size and accelerated epithelial repair, although only at pH 3 did omeprazole further increase surface pH above the level caused by imposed damage. | Gut. 2012 Jun;61(6):804-11 |
Mice | Acute esophagitis model | Subcutaneous injection | 400 μmol/kg | Single dose administered 1 hour before surgery | Omeprazole significantly reduced MPO activity and pathological damage scores in wild-type mice, similar to the effect of the VR-1 antagonist capsazepine. | Gut. 2006 Jan;55(1):34-40 |
C57BL/6 wild-type male mice | LPS-induced acute lung injury (ALI) model | Intratracheal injection | 75 μg/kg Nano-OM | Single dose, samples collected after 24 hours | Evaluate the therapeutic effect of nano-omeprazole on ALI, results showed nano-omeprazole reduced inflammatory cell infiltration and cytokine production, protecting the lungs from injury | Adv Sci (Weinh). 2022 Jan;9(3):e2104051. |
INS-GAS mice | H. pylori infection model | Oral | 400 μmol/kg/d | Twice daily for 7 days | To evaluate the efficacy of omeprazole combined with antibiotics in preventing the progression of gastric cancer in H. pylori-infected mice. Results showed that early treatment (8 weeks) completely prevented the development of GIN, while treatments at 12 and 22 weeks also significantly reduced the severity of GIN. | Cancer Res. 2008 May 1;68(9):3540-8 |
Male C57BL/6JJcl mice | High-fructose diet-induced small intestine injury model | Intraperitoneal injection | 20 mg/kg | Once daily for 9 weeks | Omeprazole exacerbated ASA-induced intestinal damage, significantly decreased Bifidobacteria levels, and significantly increased A. muciniphila counts in the jejunum. | Gut Microbes. 2020 Sep 2;11(5):1385-1404 |
计算器 | ||||
存储液制备 | ![]() |
1mg | 5mg | 10mg |
1 mM 5 mM 10 mM |
2.72mL 0.54mL 0.27mL |
13.61mL 2.72mL 1.36mL |
27.22mL 5.44mL 2.72mL |
CAS号 | 95510-70-6 |
分子式 | C17H18N3NaO3S |
分子量 | 367.4 |
SMILES Code | O=S(C1=NC2=CC=C(OC)C=C2[N-]1)CC3=NC=C(C)C(OC)=C3C.[Na+] |
MDL No. | MFCD07802816 |
别名 | H 16868 sodium |
运输 | 蓝冰 |
存储条件 |
In solvent -20°C: 3-6个月 -80°C: 12个月 Pure form Sealed in dry,2-8°C |
溶解方案 |
DMSO: 120 mg/mL(326.62 mM),配合低频超声助溶,注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO H2O: 5.5 mg/mL(14.97 mM),配合低频超声助溶 以下溶解方案都请先按照体外实验的方式配制澄清的储备液,再依次添加助溶剂: ——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议现用现配,当天使用; 以下溶剂前显示的百分比是指该溶剂在终溶液中的体积占比;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶
|